Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
EC-5026 by Eicosis for Diabetic Neuropathic Pain: Likelihood of Approval
EC-5026 is under clinical development by Eicosis and currently in Phase I for Diabetic Neuropathic Pain. According to GlobalData, Phase...
EC-5026 by Eicosis for Inflammatory Pain: Likelihood of Approval
EC-5026 is under clinical development by Eicosis and currently in Phase I for Inflammatory Pain. According to GlobalData, Phase I...
EC-5026 by Eicosis for Osteoarthritis Pain: Likelihood of Approval
EC-5026 is under clinical development by Eicosis and currently in Phase I for Osteoarthritis Pain. According to GlobalData, Phase I...